
Herbert Goldstein
Examiner (ID: 18423)
| Most Active Art Unit | 2608 |
| Art Unit(s) | 2607, 2403, 2616, 2613, 2214, 2605, 2611, 2608 |
| Total Applications | 1485 |
| Issued Applications | 1358 |
| Pending Applications | 2 |
| Abandoned Applications | 125 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16376649
[patent_doc_number] => 20200325491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR
[patent_app_type] => utility
[patent_app_number] => 16/887833
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16887833
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/887833 | Method of increasing the function of an AAV vector | May 28, 2020 | Issued |
Array
(
[id] => 17748574
[patent_doc_number] => 20220226777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Raw Material Liquid Concentration System
[patent_app_type] => utility
[patent_app_number] => 17/614085
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614085
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614085 | Raw material liquid concentration system | May 28, 2020 | Issued |
Array
(
[id] => 18070572
[patent_doc_number] => 11529388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Peptide-polynucleotide-hyaluronic acid nanoparticles and methods for polynucleotide transfection
[patent_app_type] => utility
[patent_app_number] => 16/870035
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 17441
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870035
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870035 | Peptide-polynucleotide-hyaluronic acid nanoparticles and methods for polynucleotide transfection | May 7, 2020 | Issued |
Array
(
[id] => 17067580
[patent_doc_number] => 20210269795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => Type VI-E and Type VI-F CRISPR-Cas System and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/864982
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864982
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864982 | Type VI-E and type VI-F CRISPR-Cas system and uses thereof | Apr 30, 2020 | Issued |
Array
(
[id] => 17774853
[patent_doc_number] => 20220241202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => METHOD AND VEHICLE FOR DELIVERING AGENTS ACROSS THE BLOOD-BRAIN BARRIER
[patent_app_type] => utility
[patent_app_number] => 17/606371
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606371 | METHOD AND VEHICLE FOR DELIVERING AGENTS ACROSS THE BLOOD-BRAIN BARRIER | Apr 23, 2020 | Pending |
Array
(
[id] => 16361383
[patent_doc_number] => 20200318134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => METHODS FOR SCARLESS INTRODUCTION OF TARGETED MODIFICATIONS INTO TARGETING VECTORS
[patent_app_type] => utility
[patent_app_number] => 16/838621
[patent_app_country] => US
[patent_app_date] => 2020-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16838621
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/838621 | Methods for scarless introduction of targeted modifications into targeting vectors | Apr 1, 2020 | Issued |
Array
(
[id] => 17885222
[patent_doc_number] => 20220300699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => COMBINATION THERAPY TO TREAT CANCER AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/599618
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599618
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599618 | COMBINATION THERAPY TO TREAT CANCER AND USES THEREOF | Mar 26, 2020 | Abandoned |
Array
(
[id] => 19291801
[patent_doc_number] => 12031149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Compositions and methods for promoting gene editing of CXCR4 gene
[patent_app_type] => utility
[patent_app_number] => 16/833119
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19461
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16833119
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/833119 | Compositions and methods for promoting gene editing of CXCR4 gene | Mar 26, 2020 | Issued |
Array
(
[id] => 16283986
[patent_doc_number] => 20200277588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => Engineered Cascade Components and Cascade Complexes
[patent_app_type] => utility
[patent_app_number] => 16/824603
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16824603
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/824603 | Engineered cascade components and cascade complexes | Mar 18, 2020 | Issued |
Array
(
[id] => 16112307
[patent_doc_number] => 20200208176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR
[patent_app_type] => utility
[patent_app_number] => 16/818130
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818130 | METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR | Mar 12, 2020 | Abandoned |
Array
(
[id] => 17639907
[patent_doc_number] => 20220167645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => METHODS OF IMPROVING FISH FEED CONVERSION RATE AND SURVIVAL
[patent_app_type] => utility
[patent_app_number] => 17/437216
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437216
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437216 | METHODS OF IMPROVING FISH FEED CONVERSION RATE AND SURVIVAL | Mar 10, 2020 | Abandoned |
Array
(
[id] => 16253824
[patent_doc_number] => 20200263198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => METHODS AND COMPOSITIONS FOR IN SITU GERMLINE GENOME ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 16/799398
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799398
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/799398 | Methods and compositions for in situ germline genome engineering | Feb 23, 2020 | Issued |
Array
(
[id] => 18751328
[patent_doc_number] => 11810646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Synthetic biology tools
[patent_app_type] => utility
[patent_app_number] => 16/789993
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 39
[patent_no_of_words] => 27523
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16789993
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/789993 | Synthetic biology tools | Feb 12, 2020 | Issued |
Array
(
[id] => 20608327
[patent_doc_number] => 12583915
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-24
[patent_title] => Methods for diagnosing cancer using anti-BAG2 antibody
[patent_app_type] => utility
[patent_app_number] => 16/758934
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 4438
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758934
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758934 | Methods for diagnosing cancer using anti-BAG2 antibody | Feb 11, 2020 | Issued |
Array
(
[id] => 17368193
[patent_doc_number] => 20220023245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING OR LIMITING DEVELOPMENT OF AGE-RELATED MACULAR DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/427370
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/427370 | Compositions and methods for treating or limiting development of age-related macular degeneration | Jan 29, 2020 | Issued |
Array
(
[id] => 17533642
[patent_doc_number] => 20220112251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => ENGINEERED LYSIN-HUMAN DEFENSIN PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/417587
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17417587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/417587 | ENGINEERED LYSIN-HUMAN DEFENSIN PROTEIN | Dec 22, 2019 | Pending |
Array
(
[id] => 15861325
[patent_doc_number] => 20200138066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => RECOMBINANT ANIMAL-FREE FOOD COMPOSITIONS AND METHODS OF MAKING THEM
[patent_app_type] => utility
[patent_app_number] => 16/701022
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16701022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/701022 | Recombinant animal-free food compositions and methods of making them | Dec 1, 2019 | Issued |
Array
(
[id] => 15994083
[patent_doc_number] => 20200172912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => GENOME EDITING USING CAMPYLOBACTER JEJUNI CRISPR/CAS SYSTEM-DERIVED RGEN
[patent_app_type] => utility
[patent_app_number] => 16/700942
[patent_app_country] => US
[patent_app_date] => 2019-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/700942 | GENOME EDITING USING CAMPYLOBACTER JEJUNI CRISPR/CAS SYSTEM-DERIVED RGEN | Dec 1, 2019 | Abandoned |
Array
(
[id] => 16328777
[patent_doc_number] => 20200299743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => EARLY POST-TRANSFECTION ISOLATION OF CELLS (EPIC) FOR BIOLOGICS PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 16/683837
[patent_app_country] => US
[patent_app_date] => 2019-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16683837
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/683837 | Early post-transfection isolation of cells (EPIC) for biologics production | Nov 13, 2019 | Issued |
Array
(
[id] => 19061226
[patent_doc_number] => 11940452
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => HDL-associated protein extraction and detection
[patent_app_type] => utility
[patent_app_number] => 16/667016
[patent_app_country] => US
[patent_app_date] => 2019-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 3979
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 320
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16667016
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/667016 | HDL-associated protein extraction and detection | Oct 28, 2019 | Issued |